• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Transition Therapeutics Inc

+ Add to Watchlist

TTHI:US

6.2500 USD 0.1400 2.19%

As of 20:10:00 ET on 07/25/2014.

Snapshot for Transition Therapeutics Inc (TTHI)

Open: 6.3600 Day's Range: 6.2500 - 6.4500 Volume: 24,959
Previous Close: 6.3900 52wk Range: 3.9300 - 8.2200 1-Yr Rtn: +46.71%

Stock Chart for TTHI

No chart data available.
  • TTHI:US 6.2500
  • 1D
  • 1M
  • 1Y
6.3900
Interactive TTHI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TTHI

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (06/2014) -0.5970
Est. PEG Ratio -
Market Cap (M USD) 220.00
Shares Outstanding (M) 35.20
30 Day Average Volume 20,140
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/11/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TTHI

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for TTHI

Transition Therapeutics Inc. is a biopharmaceutical company focused on developing novel therapeutics in order to address global medical needs in large disease indications, including Alzheimer's disease and diabetes.

Tony F CruzChairman/CEONicole Rusaw GeorgeChief Financial Officer
Carl DamianiChief Operating OfficerAleksandra PastrakVP:Clinical Dev/Medical Ofcr
More Company Profile & Key Executives for TTHI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil